• HATU for Precision Peptide Coupling

  2026-08-16

  HATU streamlines carboxylic acid activation for demanding amide and ester formation, with practical value in peptide synthesis and medicinal chemistry. This guide connects controlled coupling conditions with the stereochemistry, selectivity, and assay strategy used to discover potent IRAP inhibitors.

• Ceramides Drive RGNNV Replication via Autophagy

  2026-08-15

  Zhang and colleagues used global lipidomics and targeted functional experiments to show that red-spotted grouper nervous necrosis virus reshapes host ceramide metabolism and uses ceramide accumulation to support replication. The work connects capsid-protein activity, sphingolipid pathways, and autophagy, providing a mechanistic framework for studying antiviral intervention in aquaculture rather than treating lipid changes as passive infection markers.

• Anti-Inflammatory Airway Stent Limits Tracheal Restenosis

  2026-08-14

  Zhao and colleagues developed PAGL, an electrospun airway stent combining anlotinib hydrochloride with silver nanoparticles to address inflammation, infection, angiogenesis, and fibroblast activation in tracheal in-stent restenosis. The study supports a multifunctional stent strategy, while its rabbit and transcriptomic data also identify important questions for clinical translation.

• A-1210477 Workflow for MCL-1 Apoptosis

  2026-08-14

  A-1210477 is a selective MCL-1 inhibitor for resolving whether cancer-cell survival depends on the MCL-1–BIM axis and mitochondrial apoptosis. This practical workflow covers stock handling, dose-response design, combination testing, assay selection, and troubleshooting for reproducible in vitro cancer research.

• Fludarabine in Hematologic Assays: A Sequencing Lens

  2026-08-13

  Fludarabine is a DNA synthesis inhibitor with value beyond a single cytotoxicity endpoint. This guide connects its F-ara-ATP mechanism with genotype-aware assay design, helping leukemia research and multiple myeloma research teams distinguish replication stress, cell-cycle arrest, and apoptosis.

• Epoxomicin and ER Stress: Translational Proteasome Logic

  2026-08-13

  Epoxomicin is a selective, irreversible proteasome inhibitor that can help translational researchers connect protein degradation, ER stress, and disease-model phenotypes. This thought-leadership guide integrates the UBR1/UBR2 ER-stress findings with practical assay design, competitive positioning, and responsible translational interpretation.

• Hoechst 33342/PI Double Staining Kit for RCC

  2026-08-12

  Apply dual nuclear and membrane-integrity fluorescence to distinguish viable, apoptotic, and necrotic renal cell carcinoma cells after esculin treatment. This practical workflow shows how to pair the Hoechst 33342/PI Double Staining Kit with viability, proliferation, migration, and protein assays for stronger mechanistic conclusions.

• GW4064 in FXR Signaling and Fibrosis Research

  2026-08-12

  GW4064 is a selective, non-steroidal FXR agonist for separating receptor-driven signaling from nanoparticle-induced stress in cell and metabolic models. This practical guide explains how to build dose-response, fibrosis, lipid-regulation, and pathway-validation workflows while managing solubility, light sensitivity, and vehicle effects.

• Cy5 amine (non-sulfonated): Labeling Guide

  2026-08-11

  Cy5 amine (non-sulfonated) provides a primary amino group for covalent attachment to activated biomolecules while delivering red fluorescence near 662 nm. Its water-insoluble profile requires preparation in DMSO or ethanol before transfer into an appropriate aqueous labeling workflow, and it is not intended for diagnostic or medical use.

• D-N-Acetylgalactosamine: Workflow Guide

  2026-08-11

  D-N-Acetylgalactosamine provides a high-purity, water-soluble reagent for glycoprotein composition, glycosylation pathway, and brain heteropolysaccharides analysis. It is suitable for aqueous or DMSO-based workflows, but not for ethanol-based preparation or long-term storage of working solutions.

• Exemestane: Steroidal Aromatase Inhibitor Guide

  2026-08-10

  Exemestane is a steroidal aromatase inhibitor that produces mechanism-based, irreversible inhibition of CYP19A1 and reduces estrogen biosynthesis. Its defined biochemical potency, steroidal structure, and product-specific handling profile support controlled use in breast cancer research and hormone-biology assays.

• Fosinopril sodium Workflows for ACE Research

  2026-08-09

  Build prodrug-aware ACE inhibition assays, hypertension research workflows, and cardiovascular disease models around Fosinopril sodium. This guide pairs practical formulation and exposure controls with catalpol-informed cardiac, vascular, and renal endpoints for more interpretable translational data.

• 4-MUG: A Functional Readout of Lysosomal GCase

  2026-08-08

  4-Methylumbelliferyl-β-D-Glucopyranoside (4-MUG) converts glycosidase activity into a measurable fluorescent signal. This guide explains how to interpret that signal in lysosomal biology, Gaucher disease models, and translational enzyme-restoration studies.

• Fractional Killing by High-Throughput Microscopy

  2026-08-07

  The reference protocol establishes a time-resolved, high-throughput microscopy workflow for measuring the fraction of cells killed by anticancer treatments rather than relying only on population-level endpoint viability. Its use of fluorescent live-cell labeling, dead-cell detection, and parallel imaging provides a practical framework for comparing heterogeneous responses to mitogen-activated protein kinase pathway inhibitors.

• α-Amanitin for Transcriptional Regulation: Advanced Protocol

  2026-08-07

  α-Amanitin enables precise, selective inhibition of RNA polymerase II, empowering researchers to dissect gene expression pathways at single-cell and developmental scales. This guide delivers stepwise workflows, troubleshooting strategies, and practical interpretations of breakthrough findings in oocyte chromatin reorganization and transcriptional regulation research.

11626 records 1/776 page Next 12345 下5页 Last page